Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study
| Autor: | Roman Rouzier, Delphine Hequet, Fabien Reyal, Alexandra Arfi, Sandrine Baffert, Cyrille Huchon, Souhir Neffati, Bernard Asselain, Anne-Laure Soilly |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Adult
medicine.medical_specialty medicine.medical_treatment Antineoplastic Agents Breast Neoplasms breast tumours Severity of Illness Index 03 medical and health sciences 0302 clinical medicine Breast cancer Return to Work Internal medicine Severity of illness Medicine Humans 030212 general & internal medicine Prospective Studies Radical surgery Prospective cohort study Lymph node Aged Univariate analysis business.industry Research public health General Medicine Middle Aged medicine.disease Radiation therapy medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis Sick leave Female Sick Leave business |
| Zdroj: | BMJ Open |
| ISSN: | 2044-6055 |
| Popis: | IntroductionReturn to work (RTW) after breast cancer (BC) is still a new field of research. The factors determining shorter sick leave duration of patients with BC have not been clearly identified. The aim of this study was to describe work during BC treatment and to identify factors associated with sick leave duration.Materials and methodsAn observational, prospective, multicentre study was conducted among women with operable BC. A logbook was given to all working patients to record sociodemographic and work-related data over a 1-year period.ResultsWork-related data after BC were available for 178 patients (60%). The median age at diagnosis was 50 years (27–77), 87.9% of patients had an invasive form of BC and 25.3% a lymph node involvement. 25.9% had a radical surgery and 24.2% had an axillary dissection. Radiotherapy was performed in 90.9% of patients and chemotherapy in 48.1%. Sick leave was prescribed for 165 patients (92.7%) for a median of 155 days. On univariate analysis, invasive BC (p=0.025), lymph node involvement (p=0.005), radical surgery (p=0.025), axillary dissection (p=0.004), chemotherapy (pConclusionAdvanced disease and chemotherapy are major factors that influence sick leave duration during the management of BC.Trial registration numberNCT02813317. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|